Il convient plutot de s’attacher à ce que signifie ȇtre un homme, avant de problématiser la folie en terms de santé et maladie, Ludwig Binswanger, Le Rȇve et l’Existence (1954)
On a cold winter morning I walked on Independence Avenue, Windhoek’s main thoroughfare in the heart of the capital’s central business district, with M. …
Recently the Minister of Health of Trinidad and Tobago explained the problem of chronic disease in the country: “The population do not listen to the message we are sending out – love yourself, eat right, exercise and decrease your sugar and salt intake.”[i] The exhortation to “love yourself” in a disciplined approach to health suggests the curious place of …
Comics & Medicine: From Private Lives to Public Health
June 26th to 28th, 2014
The Johns Hopkins Medical Campus, Baltimore, Maryland, USA
Keynote Speakers: Ellen Forney, Arthur W. Frank, James Sturm & Carol Tilley
The Johns Hopkins University School of Medicine Department of Art as Applied to Medicine in collaboration with Graphic Medicine invites papers for the fifth Comics & …
Plasticity and Pathology: History and Theory of Neural Subjects
Organized by David Bates and Nima Bassiri
Friday, April 11
1.00 pm Welcome from Workshop Organizers (David Bates and Nima Bassiri)
1.15 – 3.15 pm Session One
Laura Salisbury (English, Exeter)
TBA [On narrative and neural subjects in Luria]
Nima Bassiri (ACLS Fellow, Literature and Neuroscience, Duke)
“Epileptic Insanity and Personal …
The brain speaks the truth of the self. I imagine it would not be controversial by now to suggest that this general formulation indexes a set of implicit constraints that have to some significant degree underwritten and informed the historical ontology of the modern self since the nineteenth century.
But let me be clear: to assert that the brain speaks …
Deep brain stimulation (DBS) involves using a pacemaker-like device to deliver constant, carefully targeted electrical stimulation to areas within the brain. It was first approved in the late 1990s as a therapy for managing the symptoms of Parkinson’s disease. The initial success of DBS led clinicians and device manufacturers to explore other possible applications, and in 2003 it was approved …